Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
4
×
life sciences
national blog main
san francisco blog main
4
×
san francisco top stories
boston blog main
raleigh-durham blog main
san diego blog main
san diego top stories
san francisco
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
raleigh-durham top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
3d imaging
aimmune therapeutics
allergy
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
anaphylaxis
andrew oxtoby
What
drug
4
×
therapy
4
×
developers
fda
patients
therapeutics
agency
aimmune
allergy
approval
approved
aren’t
awarded
bio
building
daunting
deal
developed
developer
disease
drugs
established
firm
firms
friday
gene
healthcare
help
imminent
immunotherapy
late
long
lung
markets
maze
medicare
mindmaze
momentum
moves
news
Language
unset
Current search:
drug
×
fda
×
" san francisco blog main "
×
therapy
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed